The selective bridging and binding capacities of 3WJ/PSMAapt/CD28apt NPs to CD8+ T cells and PSMA+ tumor cells were determined using CellTracker Green CMFDA and Red CMTPX pre-stained CD8+ T cells and tumor cells, respectively. This evidence concerns the gene CD8A and neoplasm.